KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Accounts Payables: 2009-2024

Historic Accounts Payables for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $140.3 million.

  • Charles River Laboratories International's Accounts Payables rose 24.75% to $169.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.6 million, marking a year-over-year increase of 24.75%. This contributed to the annual value of $140.3 million for FY2024, which is 16.93% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Accounts Payables of $140.3 million as of FY2024, which was down 16.93% from $168.9 million recorded in FY2023.
  • Charles River Laboratories International's Accounts Payables' 5-year high stood at $205.9 million during FY2022, with a 5-year trough of $122.5 million in FY2020.
  • Its 3-year average for Accounts Payables is $171.7 million, with a median of $168.9 million in 2023.
  • As far as peak fluctuations go, Charles River Laboratories International's Accounts Payables soared by 61.77% in 2021, and later dropped by 17.96% in 2023.
  • Over the past 5 years, Charles River Laboratories International's Accounts Payables (Yearly) stood at $122.5 million in 2020, then surged by 61.77% to $198.1 million in 2021, then rose by 3.93% to $205.9 million in 2022, then dropped by 17.96% to $168.9 million in 2023, then dropped by 16.93% to $140.3 million in 2024.